James Shope, MD
Plastic and Reconstructive Surgery · Martins Ferry, OHNPI 1306831177
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $602 and has fallen 86.9% since, to $79 in 2025.
Across 32 payments — averaging $59.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$245
- Medtronic$209
- Abbott$205
- AbbVie$202
- Phathom Pharmaceuticals, Inc.$180
- Dexcom, Inc.$154
- plus $716 from 11 others
What the payments were for
- Food & beverage$1,912100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 5 | $245 |
| Medtronic | 2 | $209 |
| Abbott | 3 | $205 |
| AbbVie | 3 | $202 |
| Phathom Pharmaceuticals, Inc. | 2 | $180 |
| Dexcom, Inc. | 1 | $154 |
| Novo Nordisk | 5 | $148 |
| Reprise Biomedical, Inc. | 2 | $110 |
| Flowonix Medical Incorporated | 1 | $98 |
| Edwards Lifesciences | 1 | $69 |
| Johnson & Johnson | 1 | $66 |
| Lundbeck LLC | 1 | $60 |
| Amgen | 1 | $54 |
| Novartis | 1 | $50 |
| Grifols USA, LLC | 1 | $28 |
| Mentor Worldwide LLC | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G7 GSS (161)$154
- VOQUEZNA$130
- IN.PACT Admiral$119
- QULIPTA$110
- Miroderm$103
- MIROFLEX$103
How this compares
$1,912 in reported general payments places this provider in the 55th percentile of 78 plastic and reconstructive surgery providers in Ohio.
See all plastic and reconstructive surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 57 | $308 |
| Tramadol Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Martins Ferry
- Paul VanekMentor$91K
- Richard SimmanToledo$76K
- Sunishka WimalawansaBeavercreek$68K
- James GatherwrightCleveland$52K
- Matthew GoldschmidtIndependence$47K
- Katherine GrawePowell$44K
- Abeer KalandarCleveland$34K
- David MegeeCincinnati$25K
- William AbouhassanColumbus$19K
- Todd HicksDayton$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.